Literature DB >> 23154401

Laminin-211 in skeletal muscle function.

Johan Holmberg1, Madeleine Durbeej.   

Abstract

A chain is no stronger than its weakest link is an old idiom that holds true for muscle biology. As the name implies, skeletal muscle's main function is to move the bones. However, for a muscle to transmit force and withstand the stress that contractions give rise to, it relies on a chain of proteins attaching the cytoskeleton of the muscle fiber to the surrounding extracellular matrix. The importance of this attachment is illustrated by a large number of muscular dystrophies caused by interruption of the cytoskeletal-extracellular matrix interaction. One of the major components of the extracellular matrix is laminin, a heterotrimeric glycoprotein and a major constituent of the basement membrane. It has become increasingly apparent that laminins are involved in a multitude of biological functions, including cell adhesion, differentiation, proliferation, migration and survival. This review will focus on the importance of laminin-211 for normal skeletal muscle function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154401      PMCID: PMC3544775          DOI: 10.4161/cam.22618

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  110 in total

Review 1.  Functional sites in the laminin alpha chains.

Authors:  Nobuharu Suzuki; Fumiharu Yokoyama; Motoyoshi Nomizu
Journal:  Connect Tissue Res       Date:  2005       Impact factor: 3.417

2.  Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice.

Authors:  C Florian Bentzinger; Patrizia Barzaghi; Shuo Lin; Markus A Ruegg
Journal:  FASEB J       Date:  2005-06       Impact factor: 5.191

Review 3.  Structural and genetic analysis of laminin-nidogen interaction.

Authors:  U Mayer; E Kohfeldt; R Timpl
Journal:  Ann N Y Acad Sci       Date:  1998-10-23       Impact factor: 5.691

4.  Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy.

Authors:  Marni D Boppart; Dean J Burkin; Stephen J Kaufman
Journal:  Biochim Biophys Acta       Date:  2011-01-07

5.  Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy.

Authors:  Jachinta E Rooney; Jolie R Knapp; Bradley L Hodges; Ryan D Wuebbles; Dean J Burkin
Journal:  Am J Pathol       Date:  2012-02-06       Impact factor: 4.307

6.  Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Mary Lou Beermann; Vivek K Vishnudas; Sachiko Homma; Jeffrey Boone Miller
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

7.  Primary structure of dystrophin-related protein.

Authors:  J M Tinsley; D J Blake; A Roche; U Fairbrother; J Riss; B C Byth; A E Knight; J Kendrick-Jones; G K Suthers; D R Love
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

8.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

9.  Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice.

Authors:  B L Patton; J H Miner; A Y Chiu; J R Sanes
Journal:  J Cell Biol       Date:  1997-12-15       Impact factor: 10.539

10.  A central function for perlecan in skeletal muscle and cardiovascular development.

Authors:  Jason J Zoeller; Angela McQuillan; John Whitelock; Shiu-Ying Ho; Renato V Iozzo
Journal:  J Cell Biol       Date:  2008-04-21       Impact factor: 10.539

View more
  52 in total

1.  Peptide-modified chitosan hydrogels promote skin wound healing by enhancing wound angiogenesis and inhibiting inflammation.

Authors:  Xionglin Chen; Min Zhang; Xueer Wang; Yinghua Chen; Yuan Yan; Lu Zhang; Lin Zhang
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Enzymatically crosslinked gelatin-laminin hydrogels for applications in neuromuscular tissue engineering.

Authors:  Rachel R Besser; Annie C Bowles; Ahmad Alassaf; Daniel Carbonero; Isabella Claure; Ellery Jones; Joseph Reda; Laura Wubker; Wyndham Batchelor; Noël Ziebarth; Risset Silvera; Aisha Khan; Renata Maciel; Mario Saporta; Ashutosh Agarwal
Journal:  Biomater Sci       Date:  2020-01-21       Impact factor: 6.843

3.  The laminin family: founding members of the basement membrane.

Authors:  Patricia Simon-Assmann
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

Review 4.  Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.

Authors:  Alec S T Smith; Jennifer Davis; Gabsang Lee; David L Mack; Deok-Ho Kim
Journal:  Drug Discov Today       Date:  2016-04-22       Impact factor: 7.851

5.  Influence of ovarian muscle contraction and oocyte growth on egg chamber elongation in Drosophila.

Authors:  Darcy Andersen; Sally Horne-Badovinac
Journal:  Development       Date:  2016-03-07       Impact factor: 6.868

6.  Measurement of Skeletal Muscle Fiber Contractility with High-Speed Traction Microscopy.

Authors:  Martin Rausch; David Böhringer; Martin Steinmann; Dirk W Schubert; Stefan Schrüfer; Christoph Mark; Ben Fabry
Journal:  Biophys J       Date:  2019-12-24       Impact factor: 4.033

Review 7.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

Review 8.  G Protein-Coupled Receptors in Myelinating Glia.

Authors:  Amit Mogha; Mitchell D'Rozario; Kelly R Monk
Journal:  Trends Pharmacol Sci       Date:  2016-09-23       Impact factor: 14.819

Review 9.  The role of laminins in the organization and function of neuromuscular junctions.

Authors:  Robert S Rogers; Hiroshi Nishimune
Journal:  Matrix Biol       Date:  2016-09-07       Impact factor: 11.583

Review 10.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.